Health Care & Life Sciences » Pharmaceuticals | Valeant Pharmaceuticals International Inc.

Valeant Pharmaceuticals International Inc. | Ownership

Companies that own Valeant Pharmaceuticals International Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Paulson & Co., Inc.
20,839,035
5.96%
0
9.05%
06/30/2018
ValueAct Capital Management LP
18,033,149
5.16%
21,612
2.79%
06/30/2018
The Vanguard Group, Inc.
8,331,357
2.38%
223,839
0.01%
06/30/2018
Connor, Clark & Lunn Investment Management Ltd.
7,902,892
2.25%
-1,005,185
0.94%
06/30/2018
Dimensional Fund Advisors LP
5,518,308
1.58%
-178,040
0.03%
06/30/2018
Miller Value Partners LLC
4,999,064
1.43%
-415,000
3.87%
06/30/2018
Renaissance Technologies LLC
4,093,589
1.17%
-882,100
0.1%
06/30/2018
AQR Capital Management LLC
3,597,551
1.03%
1,652,093
0.07%
06/30/2018
Fidelity (Canada) Asset Management ULC
3,560,396
1.02%
1,894,596
0.12%
06/30/2018
BMO Asset Management, Inc.
3,108,866
0.89%
-49,623
0.1%
06/30/2018

About Valeant Pharmaceuticals International

View Profile
Address
2150 St. Elzéar Boulevard West
Laval Québec H7L 4A8
Canada
Employees -
Website http://www.bauschhealth.com
Updated 07/08/2019
Bausch Health Cos. , Inc. engages in the development, manufacture, and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Branded Rx, and U.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.